Latest News:
  • Renzo Galanello Fellowship Programme 2019
  • NTWS organized the 9th National Thalassaemia Conference in New Delhi
  • Sir David Weatherall, an ‘iconic’ scientist who carried out groundbreaking work in thalassaemia, dies
  • TIF SURVEY – State provided social benefits for people with thalassaemia
  • Patients’ perspective on Genome Editing
ardeelenfrit

TIFTIF

  • About
  • Education
  • Country work
  • Positions & Policies
  • Projects
  • Publications
  • News & Events
  • Contact
Home » Clinical Trials – Press Announcements

Clinical Trials – Press Announcements

Protagonist Therapeutics (PTGX) Announces FDA Granted Orphan Drug Designation for PTG-300 for Treatment of Beta-Thalassemia 

Montco biopharm firm begins human studies of iron overload therapy

La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis

 

2018-03-13
Vicky Antoniadou

Quick Links

  • For Patients
  • For Healthcare Professionals
  • For Associations
  • For Supporters
  • Our Members
  • Useful Links
  • Sitemap

Quick links

  • For Patients
  • For Healthcare Professionals
  • For Associations
  • For Supporters
  • Our Members
  • Useful Links
  • Sitemap

Featured Video

More videos

Subscribe to our newsletter

Download the Apps

ThaliMe App


TIF Digital Library

Transparency Statement | Privacy Policy

Copyright TIF - 2019

Cookies

This site uses cookies. Find out more